Kapitalradar

Swiss capital increases, read from the official gazette and scored for financing rounds.

updated every weekdayrelease r10data as of 8 Oct 2026

↺ Try a rewind: Soverli AG on 24 Sep 2025, 83 days before the round was announced

Release evaluation · 7 Oct 2026 · does not rewind · rules + Claude: precision 2%–100% (n=17), recall 16/30 announced rounds · rules-only: precision 1%–99% (n=29), recall 18/30 announced rounds · Methodology

← Back to the feed

aevX Bio SA

History from 12 Nov 2025

UID
CHE-359.398.959
Legal form
AG
Canton
ZH
Founded
12 Nov 2025
Amount raised
not in the SHAB
Lead investor
not in the SHAB
Nominal capital · CHFCHF 118k
29k59k88k118k27 May 2026 · CHF 118k
  • shares
  • Vorzugsaktien Pre-Seed

Record

  1. Company formed

    Founded 12 Nov 2025

    SHAB HR01-1006527561 ↗
  2. Capital band adopted

    SHAB HR01-1006527561 ↗
  3. Capital increase

    Likely financing

    Paid in cash

    Nominal capital
    100’000 → 117’600
    Shares
    1’000’000 → 1’176’000
    New shares, % of post-step shares
    15.0% (176’000 new)
    Share classes
    1’000’000 × CHF 0.10 · 176’000 × CHF 0.10 Vorzugsaktien Pre-Seed

    Aktienkapital neu: CHF 117'600.00 [bisher: CHF 100'000.00]. Liberierung Aktienkapital neu: CHF 117'600.00 [bisher: CHF 100'000.00]. Aktien neu: 1'000'000 Namenaktien zu CHF 0.10 und 176'000 Namenaktien zu CHF 0.10 (Vorzugsaktien Pre-Seed) [bisher: 1'000'000 Namenaktien zu CHF 0.10]. Die Gesellschaft hat mit Beschluss vom 19.05.2026 ein Kapitalband gemäss näherer Umschreibung in den Statuten beschlossen. [bisher: L'assemblée générale a introduit une clause statutaire relative à une marge de fluctuation du capital-actions par décision du 12.11.2025; pour les détails, voir les statuts]. Vinkulierung neu: Die Übertragbarkeit der Namenaktien ist nach Massgabe der Statuten beschränkt.

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
    • The company was founded less than six years before this capital increase.+0.5
    • The company's purpose describes technology or life-sciences development.+0.5
    • A new class of preferred shares was created.+1.5

    Classifier score 0.96 · likely-financing threshold 0.60 · not a calibrated probability

    SHAB HR02-1006659167 ↗
  4. Capital band adopted

    SHAB HR02-1006659167 ↗

Published by 31 May 2026

Latest available record · 8 Oct 2026